Table 4. Correlations between HER-receptors and NRG1 in normal and breast tumour tissue among postmenopausal women.
Normal tissue |
Tumour |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HER2 | HER3 | HER4 | NRG1 | EGFR/HER1 | HER2 | HER3 | HER4 | NRG1 | |||
Normal tissue | EGFR/HER1 | Totala | -0.371 | -0.211 | -0.197 | -0.221 | -0.004 | 0.353 | 0.307 | 0.019 | 0.125 |
ER+ | -0.183 | -0.093 | -0.153 | -0.154 | 0.017 | 0.290 | 0.222 | -0.195 | 0.082 | ||
HER2 | Total | 0.616** | 0.444* | 0.681** | 0.199 | -0.205 | -0.398 | -0.103 | 0.106 | ||
ER+ | 0.527* | 0.488* | 0.665** | 0.084 | -0.001 | -0.294 | 0.106 | 0.162 | |||
HER3 | Total | 0.182 | 0.817** | 0.343 | -0.197 | -0.269 | -0.220 | 0.091 | |||
ER+ | 0.212 | 0.911** | 0.232 | -0.055 | -0.137 | 0.121 | 0.189 | ||||
HER4 | Total | 0.324 | 0.135 | -0.133 | 0.193 | 0.372 | 0.153 | ||||
ER+ | 0.298 | 0.096 | -0.152 | 0.216 | 0.482* | 0.127 | |||||
NRG1 | Total | 0.318 | -0.031 | -0.042 | -0.038 | 0.286 | |||||
ER+ | 0.219 | 0.008 | 0.004 | 0.115 | 0.215 | ||||||
Tumour | EGFR/HER1 | Total | -0.318 | -0.450* | -0.334 | 0.606** | |||||
ER+ | -0.271 | -0.321 | -0.092 | 0.744** | |||||||
HER2 | Total | 0.532** | 0.204 | 0.076 | |||||||
ER+ | 0.564* | 0.005 | -0.222 | ||||||||
HER3 | Total | 0.480* | -0.144 | ||||||||
ER+ | 0.183 | -0.327 | |||||||||
HER4 | Total | 0.244 | |||||||||
ER+ | 0.253 |
a The total group of postmenopausal women and the subgroup of ER+ postmenopausal women.
Spearman rank correlation (two-tailed):
*P≤ 0.05
** P≤ 0.01